查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1185363

生物技術市場研究報告:按技術(基於細胞的測定,色譜法,DNA 測序),應用,區域-COVID-19,俄烏衝突和高通貨膨脹的累積影響 - 2023-2030 年全球預測

Biotechnology Market Research Report by Technology (Cell-Based Assays, Chromatography, and DNA Sequencing), Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 249 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2022年全球生物技術市場規模預計為12315億美元，預計2023年將達到11953億美元，2030年將達到35833.6億美元，預計複合年增長率為16.96%。

俄烏衝突的累積影響。

鑑於俄烏衝突造成的政治和經濟不確定性，我們不斷監測和更新我們的報告。預計將在全球範圍內產生負面影響，尤其是在東歐、歐盟、東/中亞和美國。衝突對人們的生活和生計產生了深遠影響，並普遍擾亂了貿易動態。東歐正在進行的戰爭和不確定性的潛在影響預計將對烏克蘭產生負面影響，並對俄羅斯產生嚴重的長期後果。鑑於有關供需平衡、價格壓力、對進出口和貿易的影響、衝突以及全球對沖突的反應的最新信息，本報告為全球生物技術市場提供了近期建議。

高通膨的累積效應。

世界新興經濟體的高通脹導致過去兩年整體價格上漲。整體購買力的累積侵蝕預計將對新興經濟體產生重大影響，並被認為在許多方面都很有用。本報告強調了高通脹對全球經濟長期表現的影響，並詳細介紹了財政政策如何衡量和減輕對供需、現金流和匯率的短期影響。考慮到成本推動型通脹和需求拉動型通脹的相關影響，全球生物技術市場報告提供了高通脹預期。

市場統計

該報告提供了七種主要貨幣的市場規模和預測：美元、歐元、日元、英鎊、澳元、加元和瑞士法郎，使組織領導者能夠做出更好的決策。我們幫助您做到這一點。本報告將2018年和2021年作為過去年份，2022年作為基準年，2023年作為可能年，2024-2030年作為預測期。

市場細分和覆蓋

全球生物技術市場報告確定了客戶的關鍵屬性，以定義潛在市場並確定各行業的不同需求。了解潛在客戶群的經濟體和地理位置有助於獲得業務洞察力，從而做出更好的戰略決策。在這份報告中，我們通過涵蓋各個行業的市場研究來揭示每個行業參與者戰略背後隱藏的真相，並幫助企業決定將目標鎖定在誰身上。該報告提供了具有全面行業範圍的組合子市場的綜合視圖，提供了考慮規範和法規、文化等因素的正確方法，以製定正確的市場規劃覆蓋策略。本研究報告對全球生物技術市場進行了分類，並預測了以下每個子市場的收入和趨勢：

以技術為基礎，通過基於細胞的分析、層析、DNA 測序、發酵、納米生物技術、PCR 技術、組織工程和再生來探索市場。

通過應用，我們正在研究生物信息學、食品/農業、健康、工業加工和自然資源/環境。

按地區劃分，研究在美洲、亞太地區、歐洲和中東/非洲進行。美洲還探索阿根廷、巴西、加拿大、墨西哥和美國的地區。美國在加利福尼亞州、佛羅裡達州、伊利諾伊州、紐約州、俄亥俄州、賓夕法尼亞州和德克薩斯州進行了進一步探索。亞太地區在澳大利亞、中國、印度、印度尼西亞、日本、馬來西亞、菲律賓、新加坡、韓國、台灣、泰國和越南得到進一步探索。歐洲/中東/非洲包括丹麥、埃及、芬蘭、法國、德國、以色列、意大利、荷蘭、尼日利亞、挪威、波蘭、卡塔爾、俄羅斯、沙特阿拉伯、南非、西班牙、瑞典、瑞士、土耳其、阿拉伯聯合酋長國，進一步研究英國。

FPNV定位矩陣。

FPNV 定位矩陣：全球生物技術市場供應商的評級和分類。四個像限（F：Forefront，P：Pathfinder，N：Niche，V：Vital）。全球生物技術市場的 FPNV 定位表示/可視化進一步幫助公司做出更好的決策和了解競爭格局。

市場份額分析：

市場份額分析分析了供應商對整個市場的貢獻，並提供了與同一領域的其他供應商相比，整個市場的創收情況。這可以深入了解供應商在創收和客戶群方面相對於其他供應商的表現。全球生物技術市場份額分析揭示了供應商在基準年的規模和競爭力。結果揭示了市場在積累、分散、支配和合併特徵方面的特徵。

該報告提供了以下幾點的見解：

1- 市場滲透：提供主要參與者所服務市場的全面信息。

2- 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析成熟市場的滲透率。

3- 市場多元化：提供有關新產品發布、未開發領域、近期發展和投資的詳細信息

4- 市場趨勢。全面了解 COVID-19、俄烏衝突和高通脹的累積影響。

5- 競爭評估和信息：對主要參與者的市場份額、戰略、產品、認證、監管批准、專利狀態和製造能力進行深入評估。

6- 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的智力洞察。

本報告回答了以下問題：

1- 全球生物技術市場的市場規模和預測是什麼？

2- COVID-19 在預測期內塑造全球生物技術市場的抑制因素和影響是什麼？

3-在預測期內應投資全球生物技術市場的哪些產品/細分/應用/領域？

4- 全球生物技術市場的競爭戰略窗口是什麼？

5- 全球生物技術市場的技術趨勢和監管框架是什麼？

6- 全球生物技術市場主要供應商的市場份額是多少？

7- 哪些模式或戰略舉措被認為適合進入全球生物技術市場？

目錄

第一章 前言

  • 調查目的
  • 市場細分和覆蓋
  • 調查目標年份
  • 貨幣和價格
  • 語
  • 限制
  • 先決條件
  • 利益相關者

第二章研究方法論

  • 定義：研究目的
  • 決定：調查設計
  • 準備：創建問卷
  • 收集：數據源
  • 分析：數據解釋
  • 公式：數據驗證
  • 發表：研究報告創作
  • 重複：更新報告

第三章執行摘要

第四章市場概況

第 5 章市場洞察

  • 市場動態
    • 促進者
      • 對膳食補充劑和園藝產品的興趣日益增長
      • 持續健康狀況的發生率增加
      • 對個性化醫療和疾病早期發現的需求激增
    • 抑製劑
      • 與基因數據相關的風險
    • 商機
      • 創新技術的出現
      • 對農產品的需求不斷增長
    • 任務
      • 生物技術對環境的負面影響
  • COVID-19 的累積影響
  • 俄烏衝突的累積影響
  • 高通脹的累積效應
  • 波特五力分析
    • 新進入者的威脅
    • 替代品的威脅
    • 替代品的威脅
    • 替代品的威脅
    • 產業競爭力
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制

6. 生物技術市場，按技術分類

  • 基於細胞的檢測
  • 色譜法
  • DNA測序
  • 發酵
  • 納米生物技術
  • PCR技術
  • 組織工程與再生

7. 生物技術市場，按應用

  • 生物信息學
  • 食品/農業
  • 健康領域
  • 工業加工
  • 資源/環境

8.美洲生物技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第九章亞太生物技術市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 10 章歐洲/中東/非洲生物技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第十一章競爭格局

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 主要參與者的市場排名分析
  • 市場份額分析（主要參與者）
  • 主要參與者的產品組合分析
  • 競爭情景
    • 合併/收購
    • 協議、合作和夥伴關係
    • 新品發布及功能增強
    • 投資、籌款
    • 獎項/表彰/擴展

第 12 章企業可用性簡介

  • Abbott Laboratories Ltd.
  • Agilent Technologies, Inc.
  • Amgen Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Gilead Sciences, Inc.
  • Lonza Group
  • Novartis AG
  • Novo Nordisk A/S
  • PerkinElmer, Inc.
  • QIAGEN
  • Samudra Biopharma Pvt. Ltd
  • Thermo Fisher Scientific Inc

第十三章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-434CCDA04CA7

The Global Biotechnology Market size was estimated at USD 1,023.15 billion in 2022 and expected to reach USD 1,195.30 billion in 2023, projecting growth at a CAGR of 16.96% to reach USD 3,583.36 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Biotechnology Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Biotechnology Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Biotechnology Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Biotechnology Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Biotechnology Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Technology, the market is studied across Cell-Based Assays, Chromatography, DNA Sequencing, Fermentation, Nanobiotechnology, PCR Technology, and Tissue Engineering & Regeneration.

Based on Application, the market is studied across Bioinformatics, Food & Agriculture, Health, Industrial Processing, and Natural Resources & Environment.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Biotechnology Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Biotechnology Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Biotechnology Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Biotechnology Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biotechnology Market, including Abbott Laboratories Ltd., Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Gilead Sciences, Inc., Lonza Group, Novartis AG, Novo Nordisk A/S, PerkinElmer, Inc., QIAGEN, Samudra Biopharma Pvt. Ltd, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biotechnology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology Market?

4. What is the competitive strategic window for opportunities in the Global Biotechnology Market?

5. What are the technology trends and regulatory frameworks in the Global Biotechnology Market?

6. What is the market share of the leading vendors in the Global Biotechnology Market?

7. What modes and strategic moves are considered suitable for entering the Global Biotechnology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising interest for sustenance and horticultural items
      • 5.1.1.2. Growing incidence of persistent health conditions
      • 5.1.1.3. Surging demand for personalized medicines coupled with the early detection of diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Risk associated to genetic data
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of innovative technologies
      • 5.1.3.2. Escalating demand for agriculture-based products
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse environmental impact due to biotechnology
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Biotechnology Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell-Based Assays
  • 6.3. Chromatography
  • 6.4. DNA Sequencing
  • 6.5. Fermentation
  • 6.6. Nanobiotechnology
  • 6.7. PCR Technology
  • 6.8. Tissue Engineering & Regeneration

7. Biotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Bioinformatics
  • 7.3. Food & Agriculture
  • 7.4. Health
  • 7.5. Industrial Processing
  • 7.6. Natural Resources & Environment

8. Americas Biotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis, By Key Player
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Product Portfolio Analysis, By Key Player
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories Ltd.
  • 12.2. Agilent Technologies, Inc.
  • 12.3. Amgen Inc.
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. bioMerieux SA
  • 12.6. Danaher Corporation
  • 12.7. F. Hoffmann-La Roche AG
  • 12.8. General Electric Company
  • 12.9. Gilead Sciences, Inc.
  • 12.10. Lonza Group
  • 12.11. Novartis AG
  • 12.12. Novo Nordisk A/S
  • 12.13. PerkinElmer, Inc.
  • 12.14. QIAGEN
  • 12.15. Samudra Biopharma Pvt. Ltd
  • 12.16. Thermo Fisher Scientific Inc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOTECHNOLOGY MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL BIOTECHNOLOGY MARKET DYNAMICS
  • FIGURE 11. GLOBAL BIOTECHNOLOGY MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 14. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
  • FIGURE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
  • FIGURE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
  • FIGURE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
  • FIGURE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
  • FIGURE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
  • FIGURE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
  • FIGURE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
  • FIGURE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 24. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
  • FIGURE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
  • FIGURE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
  • FIGURE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
  • FIGURE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
  • FIGURE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
  • FIGURE 30. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 31. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 32. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 33. AMERICAS BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 34. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 35. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 36. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 37. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 38. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 39. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 40. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 41. UNITED STATES BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 42. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 43. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 44. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 45. ASIA-PACIFIC BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 46. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 47. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 48. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 49. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 50. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 51. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 52. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 53. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 54. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 55. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 56. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 57. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 62. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 63. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 64. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 65. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 66. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 67. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 68. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 69. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 70. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 71. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 72. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 73. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 74. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 75. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 76. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 77. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 78. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 79. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 80. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 81. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 82. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 83. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 84. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 85. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 6. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 24. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
  • TABLE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
  • TABLE 30. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 31. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 32. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
  • TABLE 33. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 34. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 35. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
  • TABLE 36. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 37. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 38. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
  • TABLE 39. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 40. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 41. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
  • TABLE 42. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 43. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 44. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 45. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 46. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 47. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 48. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 49. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 50. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 51. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 52. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 53. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 54. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 55. CANADA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 56. CANADA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 57. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 58. MEXICO BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 59. MEXICO BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 60. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 61. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
  • TABLE 62. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 63. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 64. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 65. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 66. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 67. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 68. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 69. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 70. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 71. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 72. CHINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 73. CHINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 74. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 75. INDIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 76. INDIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 77. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 78. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 79. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 80. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 81. JAPAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 82. JAPAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 83. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 84. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 85. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 86. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 87. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 88. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 89. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 90. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 91. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 92. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 93. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 94. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 95. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 96. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 97. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 98. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 99. THAILAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 100. THAILAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 101. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 102. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 103. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 108. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 109. DENMARK BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 110. DENMARK BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 111. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 112. EGYPT BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 113. EGYPT BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 114. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 115. FINLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 116. FINLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 117. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 118. FRANCE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 119. FRANCE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 120. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 121. GERMANY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 122. GERMANY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 123. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 124. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 125. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 126. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 127. ITALY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 128. ITALY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 129. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 130. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 131. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 132. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 133. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 134. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 135. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 136. NORWAY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 137. NORWAY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 138. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 139. POLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 140. POLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 141. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 142. QATAR BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 143. QATAR BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 144. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 145. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 146. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 147. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 148. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 149. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 150. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 151. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 152. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 153. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 154. SPAIN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 155. SPAIN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 156. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 157. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 158. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 159. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 160. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 161. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 162. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 163. TURKEY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 164. TURKEY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 165. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 166. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 167. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 168. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 169. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 170. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 171. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 172. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 173. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 174. GLOBAL BIOTECHNOLOGY MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 175. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 176. GLOBAL BIOTECHNOLOGY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 177. GLOBAL BIOTECHNOLOGY MARKET MERGER & ACQUISITION
  • TABLE 178. GLOBAL BIOTECHNOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 179. GLOBAL BIOTECHNOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 180. GLOBAL BIOTECHNOLOGY MARKET INVESTMENT & FUNDING
  • TABLE 181. GLOBAL BIOTECHNOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 182. GLOBAL BIOTECHNOLOGY MARKET: LICENSE & PRICING